Home › Research › Risk factors
Impact of outcome misclassification in Medicare claims on geographic differences in ADRD prevalence in Central Appalachia
Jeffrey J. Wing, Jenna I. Rajczyk, Julie Strominger, James Francis Burke. Alzheimer s & Dementia, 2025-12-01
Topic: Risk, prevention and care in population studies
Plain-language summary
All non-differential bias scenarios were biased toward the null (Table 1). In most differential scenarios, we could not say that observed differences in ADRD diagnosis were different by Appalachian County designation (Figures 1-2). However, if the sensitivity of ADRD diagnosis was more than 10-20% lower in Appalachian counties, the true prevalence difference for Appalachian compared to non-Appalachian counties ranged from 1.3% (95% SI: 0.1%, 2.2%) to 2.8% (0.2%, 4.8%) and the true prevalence ratio ranged from 1.14 (1.06, 1.17) to 1.35 (1.12, 1.63). Using claims to estimate ADRD prevalence is imperfect. We found that if ADRD diagnostic sensitivity is lower in under-resourced areas, the disparity between under-resourced and resourced regions may be substantially underestimated.
What this study adds
Evidence grade: Low
This study found that if Alzheimer's diagnosis is less sensitive in under-resourced Appalachian counties, the true difference in prevalence between Appalachian and non-Appalachian counties may be underestimated. Reported effect size: 1.3%; 0.1%; 2.2%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wing, J. J., Rajczyk, J. I., Strominger, J., & Burke, J. F. (2025). Impact of outcome misclassification in Medicare claims on geographic differences in ADRD prevalence in Central Appalachia. Alzheimer s & Dementia. https://doi.org/10.1002/alz70860_104910
Vancouver
Wing JJ, Rajczyk JI, Strominger J, Burke JF. Impact of outcome misclassification in Medicare claims on geographic differences in ADRD prevalence in Central Appalachia. Alzheimer s & Dementia. 2025. doi:10.1002/alz70860_104910. PMID: 41434871.
BibTeX
@article{wing2025-41434871,
author = {Wing, Jeffrey J. and Rajczyk, Jenna I. and Strominger, Julie and Burke, James Francis},
title = {{Impact of outcome misclassification in Medicare claims on geographic differences in ADRD prevalence in Central Appalachia}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70860_104910},
pmid = {41434871},
url = {https://doi.org/10.1002/alz70860_104910}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- All non-differential bias scenarios were biased toward the null (Table 1).
- In most differential scenarios, we could not say that observed differences in ADRD diagnosis were different by Appalachian County designation (Figures 1-2).
- However, if the sensitivity of ADRD diagnosis was more than 10-20% lower in Appalachian counties, the true prevalence difference for Appalachian compared to non-Appalachian counties ranged from 1.3% (95% SI: 0.1%, 2.2%) to 2.8% (0.2%, 4.8%) and the true prevalence ratio ranged from 1.14 (1.06, 1.17) to 1.35 (1.12, 1.63).
- Using claims to estimate ADRD prevalence is imperfect.
- We found that if ADRD diagnostic sensitivity is lower in under-resourced areas, the disparity between under-resourced and resourced regions may be substantially underestimated.
Why it matters
This study found that if Alzheimer's diagnosis is less sensitive in under-resourced Appalachian counties, the true difference in prevalence between Appalachian and non-Appalachian counties may be underestimated. It is about how disease rates are measured, not about treating, curing, or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Effect size1.3%; 0.1%; 2.2%
- Evidence strengthLow
How this study scored 34/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author James Francis Burke: h-index 61 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | The Ohio State University: institution h-index 1,378 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41434871) |
| Free to read | 2 / 2 | Free to read |
| Total | 34 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70860_104910
- PubMed: 41434871
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also in Risk factors
356 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.